Biocartesian

About

Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.

Founders

• 
  Ian Dardani· Founder

  Co-founder of Biocartesian. Microscopy + molecular tools + engineering. Previously Bioscience Enterprise at Cambridge, Bioengineering PhD at UPenn.

  LinkedIn ↗
• 
  Jess Li· Founder

  Co-founder of Biocartesian. Genetics + epigenetics, next-gen sequencing. Previously PhD at UPenn, BD at imvaria.

  LinkedIn ↗

Product launches · 1 launch

• Biocartesian - Converting biology into digital molecular maps ↗▲ 265Aug 29, 2024

  We use chemistry and microscopy to help scientists discover new drugs.

Change history · none recorded